Literature DB >> 8730801

Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity.

M A Mena1, M J Casarejos, A Carazo, C L Paino, J García de Yébenes.   

Abstract

L-DOPA kills dopamine neurones in culture but is the most effective drug for the treatment of Parkinson's disease, where it exhibits no clear toxicity. While glial cells surround and protect neurones in vivo, neurones are usually cultured in vitro in the absence of glia. We treated fetal midbrain rat neurones with L-DOPA, mesencephalic glia conditioned medium (CM) and L-DOPA + CM. L-DOPA reduced the number of tyrosine hydroxylase-positive (TH+) cells and [3H]DA uptake, and increased quinone levels. L-DOPA + CM restored [3H]DA uptake and quinone levels to normal, and increased the number of TH+ cells and terminals to 170% of control. CM greatly increased the number of TH+ cells and [3H]DA uptake. Mesencephalic glia therefore produced soluble factors which are neurotrophic for dopamine neurones, and which protect these neurones from the toxic effects of L-DOPA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730801     DOI: 10.1097/00001756-199601310-00016

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  21 in total

1.  An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor.

Authors:  D M Panchision; P A Martin-DeLeon; T Takeshima; J M Johnston; K Shimoda; P Tsoulfas; R D McKay; J W Commissiong
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

2.  Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress.

Authors:  Andy Y Shih; Delinda A Johnson; Gloria Wong; Andrew D Kraft; Lei Jiang; Heidi Erb; Jeffrey A Johnson; Timothy H Murphy
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

3.  Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms.

Authors:  M A Mena; M J Casarejos; A Carazo; C L Paíno; J García de Yébenes
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  PATHOBIOLOGY OF NEURODEGENERATION: THE ROLE FOR ASTROGLIA.

Authors:  Alexei Verkhratsky; Robert Zorec; Jose J Rodriguez; Vladimir Parpura
Journal:  Opera Med Physiol       Date:  2016-03-04

5.  Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.

Authors:  G Gille; K Radad; H Reichmann; W-D Rausch
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 6.  Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

Authors:  M G Murer; R Raisman-Vozari; O Gershanik
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

Review 7.  Neuroglial roots of neurodegenerative diseases?

Authors:  José Julio Rodríguez; Alexei Verkhratsky
Journal:  Mol Neurobiol       Date:  2010-12-15       Impact factor: 5.590

Review 8.  Does levodopa accelerate Parkinson's disease?

Authors:  T Simuni; M B Stern
Journal:  Drugs Aging       Date:  1999-06       Impact factor: 3.923

9.  The role of 3-O-methyldopa in the side effects of L-dopa.

Authors:  Eun-Sook Y Lee; Hongtao Chen; Jennifer King; Clivel Charlton
Journal:  Neurochem Res       Date:  2007-08-24       Impact factor: 3.996

Review 10.  The role of astroglia on the survival of dopamine neurons.

Authors:  María Angeles Mena; Sonsoles de Bernardo; Maria José Casarejos; Santiago Canals; Eulalia Rodríguez-Martín
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.